News Release 

Effect of ultrasound renal denervation after crossover from sham in RADIANCE-HTN SOLO

Crossover patients after initial sham procedure benefit from renal denervation by endovascular ultrasound

PCR

Control of hypertension represents an unmet need globally, and RDN is an "adherence-independent" adjunctive therapy to medications. The RADIANCE-HTN SOLO trial was a multicenter randomized controlled trial that demonstrated the blood pressure lowering effect of endovascular ultrasound-based renal denervation compared with a sham control.

We analyzed ambulatory BP and safety data from 31 patients from the sham arm of the RADIANCE-HTN SOLO trial who crossed over and received renal denervation due to elevated ambulatory blood pressures after 12 months of observation. Within this cohort, daytime ambulatory systolic BP dropped following renal denervation by 11.2 mm Hg at 2 months and 12.2 mm Hg at 6 months (p<0.001 in comparison to baseline at time of crossover for both) without an increase in medication burden. There were no major adverse events through 6 months of follow-up after crossover.

These results are consistent with the primary RADIANCE-HTN SOLO results demonstrating the blood pressure lowering effect of ultrasound-based renal denervation. Notably, crossover subjects and physicians were unblinded, so these data are subject to behavioral and/or medication-related effects. Nonetheless, these results may provide some added insights into early procedural efficacy and durability after renal denervation.

###

Notes to editors

Key information

  • A PCR Press Release on "Blood Pressure Results Following Crossover to Endovascular Ultrasound Renal Denervation in Patients in the Sham Arm of the RADIANCE-HTN SOLO Trial" by Ajay J. Kirtane
  • Presentation during the #PCR e-Course - http://www.pcr-ecourse.com
  • Session on Main Arena Channel, Friday 26 June - 14:00 Paris time (UTC+2)
  • PCR e-Course: 25, 26, 27 June 2020

About PCR

The mission of PCR is to serve the needs of each individual patient by helping the cardiovascular community to share knowledge, experience and practice. PCR offers a wide range of other educational meetings and resources for the continuing education of the interventional cardiovascular community. These include major annual Courses across the globe, e-Learning with high-profile PCR Webinars, Courses specifically dedicated to valvular heart disease, tailor-made PCR Seminars on specific topics, online resources and medical publications such as EuroIntervention, the official journal of the EAPCI.

Gateways to all PCR activities are available on http://www.pcronline.com

For further information, please contact Célia Vilà: cvila@europa-group.com

Disclaimer: AAAS and EurekAlert! are not responsible for the accuracy of news releases posted to EurekAlert! by contributing institutions or for the use of any information through the EurekAlert system.